SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009699
Filing Date
2022-05-12
Accepted
2022-05-12 16:28:09
Documents
74
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vtyx-20220331.htm   iXBRL 10-Q 3154323
2 EX-31.1 vtyx-ex31_1.htm EX-31.1 21810
3 EX-31.2 vtyx-ex31_2.htm EX-31.2 21831
4 EX-32.1 vtyx-ex32_1.htm EX-32.1 13212
5 EX-32.2 vtyx-ex32_2.htm EX-32.2 13233
  Complete submission text file 0000950170-22-009699.txt   10679939

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtyx-20220331.xsd EX-101.SCH 50072
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtyx-20220331_lab.xml EX-101.LAB 454664
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtyx-20220331_def.xml EX-101.DEF 216882
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtyx-20220331_cal.xml EX-101.CAL 52277
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtyx-20220331_pre.xml EX-101.PRE 358036
68 EXTRACTED XBRL INSTANCE DOCUMENT vtyx-20220331_htm.xml XML 2158252
Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40928 | Film No.: 22918277
SIC: 2834 Pharmaceutical Preparations